tradingkey.logo
tradingkey.logo
Search

Partner Therapeutics Announces FDA Approval Of Bizengri(Zenocutuzumab-Zbco)

ReutersMay 11, 2026 10:02 AM
facebooktwitterlinkedin
View all comments0

-

  • PARTNER THERAPEUTICS ANNOUNCES FDA APPROVAL OF BIZENGRI® (ZENOCUTUZUMAB-ZBCO) FOR NRG1 FUSION-POSITIVE CHOLANGIOCARCINOMA

Further company coverage: [ ]

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Comments (0)

Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.

0/500
Commenting Guidelines
Loading...

Recommended Articles

Tradingkey
KeyAI